11/14/2024
6:54 PM | Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/13/2024
3:34 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
8:34 AM | Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
11/04/2024
1:09 PM | Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
08/13/2024
3:31 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
3:16 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/12/2024
3:38 PM | Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
3:40 PM | Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:10 PM | Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
3:11 PM | Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:29 PM | Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
3:31 PM | Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:19 PM | Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:21 PM | Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:22 PM | Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:24 PM | Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:34 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
4:59 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:10 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:58 PM | Sutro Biopharma (Filer)
| Form 424B5 | |
04/02/2024
5:04 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:28 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4/A | |
03/07/2024
6:12 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:26 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:28 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:31 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:32 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:40 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:29 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:15 PM | Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:33 PM | Sutro Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2024
11:16 AM | Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
02/09/2024
3:27 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:56 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
01/31/2024
3:23 PM | Sutro Biopharma (Issuer)
Vasquez Nicki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
01/31/2024
3:25 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:28 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:29 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:54 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G | |
01/08/2024
6:31 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
3:19 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
11:15 PM | Sutro Biopharma (Filer)
| Form EFFECT | |
11/21/2023
3:05 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
